Antibody Stocks List

Recent Signals

Date Stock Signal Type
2021-07-23 ADAG Volume Surge Other
2021-07-23 ADMA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-23 ADMA NR7 Range Contraction
2021-07-23 ALLK Narrow Range Bar Range Contraction
2021-07-23 ALLK NR7 Range Contraction
2021-07-23 BCEL Expansion Breakdown Bearish Swing Setup
2021-07-23 BCEL New 52 Week Closing Low Bearish
2021-07-23 BCEL New 52 Week Low Weakness
2021-07-23 BCEL MACD Bearish Signal Line Cross Bearish
2021-07-23 CEMI Fell Below 50 DMA Bearish
2021-07-23 CEMI Slingshot Bullish Bullish Swing Setup
2021-07-23 CGEN New 52 Week Closing Low Bearish
2021-07-23 CGEN New 52 Week Low Weakness
2021-07-23 CGEN NR7 Range Contraction
2021-07-23 CGEN Stochastic Reached Oversold Weakness
2021-07-23 EQ NR7 Range Contraction
2021-07-23 EQ Bollinger Band Squeeze Range Contraction
2021-07-23 FSTX New Downtrend Bearish
2021-07-23 FSTX Stochastic Reached Oversold Weakness
2021-07-23 GRFS Narrow Range Bar Range Contraction
2021-07-23 GRFS 1,2,3 Retracement Bearish Bearish Swing Setup
2021-07-23 GRFS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-23 IMNM Crossed Above 20 DMA Bullish
2021-07-23 IPA Volume Surge Other
2021-07-23 IPA Jack-in-the-Box Bullish Bullish Swing Setup
2021-07-23 IPHA Narrow Range Bar Range Contraction
2021-07-23 MGNX Crossed Above 200 DMA Bullish
2021-07-23 MOR New Downtrend Bearish
2021-07-23 MOR Narrow Range Bar Range Contraction
2021-07-23 MOR Calm After Storm Range Contraction
2021-07-23 MRVI Stochastic Reached Overbought Strength
2021-07-23 MRVI NR7 Range Contraction
2021-07-23 SBTX Stochastic Sell Signal Bearish
2021-07-23 SBTX Slingshot Bullish Bullish Swing Setup
2021-07-23 SELB Calm After Storm Range Contraction
2021-07-23 SONN New 52 Week Closing Low Bearish
2021-07-23 SONN Doji - Bullish? Reversal
2021-07-23 SONN New 52 Week Low Weakness
2021-07-23 SRNE Fell Below 200 DMA Bearish
2021-07-23 SRNE Fell Below 50 DMA Bearish
2021-07-23 TECH New 52 Week High Strength
2021-07-23 TECH New 52 Week Closing High Bullish
2021-07-23 XBIT Narrow Range Bar Range Contraction
2021-07-23 XBIT NR7 Range Contraction
2021-07-23 XBIT NR7-2 Range Contraction
2021-07-23 XBIT Calm After Storm Range Contraction
2021-07-23 XNCR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-23 XOMA 20 DMA Resistance Bearish
2021-07-23 ZYME NR7 Range Contraction
2021-07-23 ZYME Fell Below 20 DMA Bearish
2021-07-23 ZYME Bollinger Band Squeeze Range Contraction
2021-07-23 ZYME Non-ADX 1,2,3,4 Bullish Bullish Swing Setup

Antibody Stocks Recent News

Date Stock Title
Jul 24 TECH If You Invested $1,000 In Disney Stock When They Acquired Pixar, Here's How Much You'd Have Now
Jul 24 TECH China Announces Ban On $100 Billion Dollar For-Profit Education Sector
Jul 24 TECH Texas Regulators Issue Cease-And-Desist Order Against Crypto Lending Platform BlockFi
Jul 24 TECH Polychain, A16z Face Unregistered Security Lawsuit Over Internet Computer Token Sale
Jul 23 TECH KFC Korea To Launch NFTs Through New Partnership
Jul 23 TECH How FAANGs Could Benefit From Chinese Regulatory Scrutiny Of Domestic Tech Stocks
Jul 23 MRVI Maravai Lifesciences Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
Jul 23 SRNE First patient enrolled in China Oncology's late-stage socazolimab lung cancer trial
Jul 23 TECH Dollars Or Pounds, What Should Trigger A Drone Accident Investigation?
Jul 23 SRNE Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, as a First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Jul 23 TECH Summit Wireless Technologies To Raise $10M Via Institutional Equity Offering At 13% Discount
Jul 23 TECH Socket Mobile Stock Jumps After Q2 Earnings Beat
Jul 23 TECH Tesla Hikes Model 3, Model Y Prices In US Yet Again
Jul 23 TECH Snapchat Parent To Add 5 New Games This Year, Highlights Augmented Reality Push
Jul 23 TECH Apple To Remove Popular DOS Emulator That Let iPhone Users Play Classic Games
Jul 23 TECH Twitter Says It Took A Smaller Hit From Apple iOS Privacy Changes Than Expected
Jul 23 TECH Snapchat Scores Exclusive Olympics Content In NBC Deal — Could It Replicate Previous Run's Success?
Jul 22 TECH This Expert Warns Bitcoin Might Be Heading For $22,000 Level
Jul 22 TECH A Dive Into Nasdaq's Q2 Earnings: They've Got The Beat!
Jul 22 TECH Snap, Twitter Surge On Q2 User Growth, Revenue Beats

An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen, via the Fab's variable region. Each tip of the "Y" of an antibody contains a paratope (analogous to a lock) that is specific for one particular epitope (similarly, analogous to a key) on an antigen, allowing these two structures to bind together with precision. Using this binding mechanism, an antibody can tag a microbe or an infected cell for attack by other parts of the immune system, or can neutralize its target directly (for example, by inhibiting a part of a microbe that is essential for its invasion and survival). Depending on the antigen, the binding may impede the biological process causing the disease or may activate macrophages to destroy the foreign substance. The ability of an antibody to communicate with the other components of the immune system is mediated via its Fc region (located at the base of the "Y"), which contains a conserved glycosylation site involved in these interactions. The production of antibodies is the main function of the humoral immune system.Antibodies are secreted by B cells of the adaptive immune system, mostly by differentiated B cells called plasma cells. Antibodies can occur in two physical forms, a soluble form that is secreted from the cell to be free in the blood plasma, and a membrane-bound form that is attached to the surface of a B cell and is referred to as the B-cell receptor (BCR). The BCR is found only on the surface of B cells and facilitates the activation of these cells and their subsequent differentiation into either antibody factories called plasma cells or memory B cells that will survive in the body and remember that same antigen so the B cells can respond faster upon future exposure. In most cases, interaction of the B cell with a T helper cell is necessary to produce full activation of the B cell and, therefore, antibody generation following antigen binding. Soluble antibodies are released into the blood and tissue fluids, as well as many secretions to continue to survey for invading microorganisms.
Antibodies are glycoproteins belonging to the immunoglobulin superfamily. They constitute most of the gamma globulin fraction of the blood proteins. They are typically made of basic structural units—each with two large heavy chains and two small light chains. There are several different types of antibody heavy chains that define the five different types of crystallisable fragments (Fc) that may be attached to the antigen-binding fragments. The five different types of Fc regions allow antibodies to be grouped into five isotypes. Each Fc region of a particular antibody isotype is able to bind to its specific Fc Receptor (except for IgD, which is essentially the BCR), thus allowing the antigen-antibody complex to mediate different roles depending on which FcR it binds. The ability of an antibody to bind to its corresponding FcR is further modulated by the structure of the glycan(s) present at conserved sites within its Fc region. The ability of antibodies to bind to FcRs helps to direct the appropriate immune response for each different type of foreign object they encounter. For example, IgE is responsible for an allergic response consisting of mast cell degranulation and histamine release. IgE's Fab paratope binds to allergic antigen, for example house dust mite particles, while its Fc region binds to Fc receptor ε. The allergen-IgE-FcRε interaction mediates allergic signal transduction to induce conditions such as asthma.Though the general structure of all antibodies is very similar, a small region at the tip of the protein is extremely variable, allowing millions of antibodies with slightly different tip structures, or antigen-binding sites, to exist. This region is known as the hypervariable region. Each of these variants can bind to a different antigen. This enormous diversity of antibody paratopes on the antigen-binding fragments allows the immune system to recognize an equally wide variety of antigens. The large and diverse population of antibody paratope is generated by random recombination events of a set of gene segments that encode different antigen-binding sites (or paratopes), followed by random mutations in this area of the antibody gene, which create further diversity. This recombinational process that produces clonal antibody paratope diversity is called V(D)J or VJ recombination. Basically, the antibody paratope is polygenic, made up of three genes, V, D, and J. Each paratope locus is also polymorphic, such that during antibody production, one allele of V, one of D, and one of J is chosen. These gene segments are then joined together using random genetic recombination to produce the paratope. The regions where the genes are randomly recombined together is the hyper variable region used to recognise different antigens on a clonal basis.
Antibody genes also re-organize in a process called class switching that changes the one type of heavy chain Fc fragment to another, creating a different isotype of the antibody that retains the antigen-specific variable region. This allows a single antibody to be used by different types of Fc receptors, expressed on different parts of the immune system.

More about Antibody
Browse All Tags